Colgate-Palmolive Partners With Verily on Oral Health Research
Colgate-Palmolive and Verily have formed a strategic collaboration to advance oral health research.
Colgate-Palmolive and Verily have formed a strategic collaboration to advance oral health research. Under the agreement, Colgate will partner with Verily to better understand how oral health practices — including nonsurgical periodontal therapy and a self-care regimen monitored through Colgate’s hum smart toothbrush technology — affect overall health.
The study will enroll subjects with prediabetes, type 2 diabetes, and/or cardiovascular disease who are current participants in Verily’s ongoing Baseline Health Study. Coinvestigators at the University of North Carolina at Chapel Hill Adams School of Dentistry will oversee nonsurgical periodontal therapy.
“Oral health is a window to overall health. It can provide signals of new or worsening disease, as exemplified by the connection between periodontal disease and elevated C-reactive protein, a marker of systemic inflammation that complicates diabetes control and increases the risk of cardiovascular disease,” notes Maria Ryan, DDS, PhD, vice president and chief clinical officer at Colgate-Palmolive. For more information on the Baseline Oral Health Study, visit projectbaseline.com.
From Decisions in Dentistry. September 2021;7(9):8.
